Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Novel Strategy for Reducing Radiation-Induced Morbidity and Treating Recurrent Medulloblasoma |
Massachusetts General Hospital / Rakesh Jain, PhD |
Reach Grants |
2013 |
Massachusetts |
Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish |
Dana-Farber Cancer Institute / Serine Avagyan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Targeted Therapy for Core Binding Factor Leukemia |
University of Massachusetts Medical School / John Pulikkan, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified |
Broad Institute / Rameen Beroukhim, MD,PhD |
Innovation Grants |
2015 |
Massachusetts |
Targeting the Mechanism of Differentiation Arrest in a Novel Model of Acute Leukemia |
Massachusetts General Hospital / David Sykes |
Young Investigator Grants |
2011 |
Massachusetts |
MYC-driven Core Regulatory Circuits in Neuroblastoma |
Dana-Farber Cancer Institute / Mark Zimmerman, PhD |
Young Investigator Grants |
2018 |
Massachusetts |